Kayyem Jon Faiz

DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Jun 4, 2024
Net Buying
Open-Market Buys
$4.9M
Open-Market Sells
$0
Net Open-Market Flow
$4.9M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 4, 2024Buy(P)65K$17.44$1.1M1.1M
Jun 4, 2024Buy(P)24K$18.24$433K1.1M
Jun 3, 2024Buy(P)81K$17.90$1.4M1.0M
Jun 3, 2024Buy(P)47K$16.61$777K923K
May 31, 2024Buy(P)70K$16.14$1.1M876K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007919-24-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly: